home / stock / bcda / bcda news

BCDA News and Press, BioCardia Inc. From 11/14/23

Stock Information
Company Name: BioCardia Inc.
Stock Symbol: BCDA
Market: NASDAQ
Website: biocardia.com
Menu
BCDA BCDA Quote BCDA Short BCDA News BCDA Articles BCDA Message Board
Get BCDA Alerts

News, Short Squeeze, Breakout and More Instantly...
BCDA - 24/7 Market News Snapshot 14 Nov 2023

2023-11-14 10:00:40 ET DENVER, Colo., Nov. 14, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; BioCardia Inc (NASDAQ: BCDA), INVO Bioscience Inc (NASDAQ: INVO), Theseus Pharmaceuticals Inc (NASDAQ: THRX),...
BCDA - BioCardia stock jumps premarket as FDA approves heart failure trial

2023-11-14 07:53:50 ET More on BioCardia BioCardia, Inc. (BCDA) Q3 2023 Earnings Call Transcript BioCardia doesn't see Phase 3 study meeting primary endpoint, stock slides Seeking Alpha’s Quant Rating on BioCardia Historical earnings data for BioCardia...

BCDA - FDA Approves BioCardia's CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure

2023-11-14 07:47:47 ET DENVER, Colo., Nov 14, 2023 ( www.247marketnews.com )- BioCardia Inc (NASDAQ: BCDA) stated, this morning, that the Food and Drug Administration (FDA) approved its Phase III clinical trial of its CardiAMP autologous cell therapy for the treatment of patients with i...

BCDA - BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure

SUNNYVALE, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the Food and Drug Administration (FDA) approval of its Phase III clinical tria...
BCDA - BioCardia, Inc. (BCDA) Q3 2023 Earnings Call Transcript

2023-11-08 20:08:03 ET BioCardia, Inc. (BCDA) Q3 2023 Earnings Conference Call November 08, 2023, 04:30 PM ET Company Participants Miranda Peto - Investor Relations Peter Altman - President and Chief Executive Officer David McClung - Chief Financial Officer ...

BCDA - BioCardia GAAP EPS of -$0.12

2023-11-08 16:51:53 ET More on BioCardia BioCardia doesn't see Phase 3 study meeting primary endpoint, stock slides Seeking Alpha’s Quant Rating on BioCardia Historical earnings data for BioCardia Financial information for BioCardia For further...

BCDA - BioCardia Reports Third Quarter 2023 Business Highlights and Financial Results

SUNNYVALE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reports financial results for the third quarter of 2023 and filed its quarterly report o...
BCDA - Expected US Company Earnings on Wednesday, November 8th, 2023

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

BCDA - Expected earnings - BioCardia Inc.

BioCardia Inc. (BCDA) is expected to report $-0.12 for Q3 2023

BCDA - BioCardia to Host Q3 2023 Corporate Update and Financial Results Conference Call on November 8, 2023

SUNNYVALE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for t...
Previous 10 Next 10